| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Marc Blockma. Selective serotonin reuptake inhibitors in children with major depression. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. vol 96. issue 6. 2006-08-04. PMID:16841124. |
selective serotonin reuptake inhibitors in children with major depression. |
2006-08-04 |
2023-08-12 |
Not clear |
| Glen L Xiong, Wei Jiang, Robert Clare, Linda K Shaw, Peter K Smith, Kenneth W Mahaffey, Christopher M O'Connor, K Ranga R Krishnan, L Kristin Newb. Prognosis of patients taking selective serotonin reuptake inhibitors before coronary artery bypass grafting. The American journal of cardiology. vol 98. issue 1. 2006-08-03. PMID:16784918. |
the use of selective serotonin reuptake inhibitors (ssris) for depression in patients with cardiac disease is becoming more prevalent. |
2006-08-03 |
2023-08-12 |
Not clear |
| Kay Wilhelm, Philip B Mitchell, Heather Niven, Adam Finch, Lucinda Wedgwood, Anna Scimone, Ian P Blair, Gordon Parker, Peter R Schofiel. Life events, first depression onset and the serotonin transporter gene. The British journal of psychiatry : the journal of mental science. vol 188. 2006-07-31. PMID:16507960. |
life events, first depression onset and the serotonin transporter gene. |
2006-07-31 |
2023-08-12 |
Not clear |
| Kay Wilhelm, Philip B Mitchell, Heather Niven, Adam Finch, Lucinda Wedgwood, Anna Scimone, Ian P Blair, Gordon Parker, Peter R Schofiel. Life events, first depression onset and the serotonin transporter gene. The British journal of psychiatry : the journal of mental science. vol 188. 2006-07-31. PMID:16507960. |
a relationship between the serotonin transporter gene, adverse events and onset of major depression has been reported. |
2006-07-31 |
2023-08-12 |
Not clear |
| A Keeney, D S Jessop, M S Harbuz, C A Marsden, S Hogg, R E Blackburn-Munr. Differential effects of acute and chronic social defeat stress on hypothalamic-pituitary-adrenal axis function and hippocampal serotonin release in mice. Journal of neuroendocrinology. vol 18. issue 5. 2006-07-27. PMID:16629831. |
these results demonstrate that social defeat induces prolonged activation of the hpa axis and alterations in 5-ht neurotransmission that could be of relevance to some of the pathological abnormalities observed in clinical depression. |
2006-07-27 |
2023-08-12 |
mouse |
| Anna Chur-Hansen, Deborah Zio. 'Let's fix the chemical imbalance first, and then we can work on the problems second': an exploration of ethical implications of prescribing an SSRI for 'depression'. Monash bioethics review. vol 25. issue 1. 2006-07-24. PMID:16832942. |
the creation of pharmacotherapies, such as selective serotonin reuptake inhibitors (ssris), for the treatment of depression was hailed as a great breakthrough in mental health care. |
2006-07-24 |
2023-08-12 |
Not clear |
| Z Walker, R W Walker, M M Robertson, S Stansfel. Antidepressant treatment of chronic tension-type headache: a comparison between fluoxetine and desipramine. Headache. vol 38. issue 7. 2006-07-21. PMID:15613168. |
in a single-blind study, patients with chronic tension-type headache were randomized to either fluoxetine 20 mg (a selective 5-ht reuptake inhibitor) or desipramine 75 mg (a selective noradrenaline reuptake inhibitor) and followed for 12 weeks to compare the effectiveness of the two drugs in improving headache, and to assess whether pain control is related to changes in depression. |
2006-07-21 |
2023-08-12 |
Not clear |
| Hideaki Mitani, Yukihiko Shirayama, Takeshi Yamada, Ryuzou Kawahar. Plasma levels of homovanillic acid, 5-hydroxyindoleacetic acid and cortisol, and serotonin turnover in depressed patients. Progress in neuro-psychopharmacology & biological psychiatry. vol 30. issue 3. 2006-07-19. PMID:16414168. |
taken together, plasma levels of hva and 5-hiaa, and 5-ht turnover (5-hiaa/5-ht) could be good markers for evaluating depression. |
2006-07-19 |
2023-08-12 |
human |
| Tasneem Z Naqvi, Syed S A Naqvi, C Noel Bairey Mer. Gender differences in the link between depression and cardiovascular disease. Psychosomatic medicine. vol 67 Suppl 1. 2006-07-18. PMID:15953793. |
pharmacologic treatment of depression with serotonin reuptake inhibitors is safe in men and women post-ami and is particularly effective in patients with recurrent depression. |
2006-07-18 |
2023-08-12 |
human |
| Steven P Roose, Marissa Miyazak. Pharmacologic treatment of depression in patients with heart disease. Psychosomatic medicine. vol 67 Suppl 1. 2006-07-18. PMID:15953802. |
although the data are limited and are primarily from open or comparator trials, the tricyclics (tcas) and selective serotonin reuptake inhibitors (ssri) are effective for treatment of depression in patients with ischemic heart disease (ihd), and response rates are comparable with those reported in depressed patients without heart disease. |
2006-07-18 |
2023-08-12 |
Not clear |
| Nancy Frasure-Smith, Diana Koszycki, John Robert Swenson, Brian Baker, Louis T van Zyl, Marc-André Laliberté, Beth L Abramson, Jean Lambert, Ginette Gravel, François Lespéranc. Design and rationale for a randomized, controlled trial of interpersonal psychotherapy and citalopram for depression in coronary artery disease (CREATE). Psychosomatic medicine. vol 68. issue 1. 2006-07-18. PMID:16449416. |
this article presents the design of a multisite, canadian trial of the efficacy, safety, and tolerability of interpersonal psychotherapy (ipt), an empirically supported, depression-focused therapy, and the selective serotonin reuptake inhibitor citalopram, alone or in combination, in the treatment of major depression in cad patients. |
2006-07-18 |
2023-08-12 |
Not clear |
| Jeanne M McCaffery, Nancy Frasure-Smith, Marie-Pierre Dubé, Pierre Théroux, Guy A Rouleau, Qingling Duan, Francois Lespéranc. Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin. Psychosomatic medicine. vol 68. issue 2. 2006-07-18. PMID:16554382. |
in this paper, we review the existing evidence for common genetic contributions to depression and cad, primarily using evidence from twin and family studies, followed by a review of two major pathophysiological mechanisms thought to underlie covariation between depressive symptoms and cad: inflammation and serotonin. |
2006-07-18 |
2023-08-12 |
human |
| About the cover: St. John's wort. Journal of the Society for Integrative Oncology. vol 4. issue 1. 2006-07-18. PMID:16737673. |
some studies comparing st. john's wort to standard antidepressants suggest that it may be as effective as imipramine or selective serotonin reuptake inhibitors (ssris) to treat mild to moderate depression. |
2006-07-18 |
2023-08-12 |
Not clear |
| Katheleen Gardiner, Yunzhi D. A-to-I editing of the 5HT2C receptor and behaviour. Briefings in functional genomics & proteomics. vol 5. issue 1. 2006-07-18. PMID:16769676. |
because serotonin functions in the regulation of mood and behaviour, modulation of serotonin signalling by rna editing may be relevant to such psychiatric disorders as anxiety and depression. |
2006-07-18 |
2023-08-12 |
mouse |
| Zsuzsa Aszaló. [Effects of antidepressants on sleep]. Orvosi hetilap. vol 147. issue 17. 2006-07-14. PMID:16780185. |
selective serotonin reuptake inhibitors, except paroxetine, improve sleep only at the time and to the extent of restoring depression. |
2006-07-14 |
2023-08-12 |
Not clear |
| Ahmad R Hariri, Andrew Holme. Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends in cognitive sciences. vol 10. issue 4. 2006-07-13. PMID:16530463. |
the emergence of techniques such as in vivo imaging of brain function in humans and genetic engineering in rodents has provided important new insights into the impact of serotonin (5-ht), a key modulator of emotional behavior, on neural systems subserving anxiety and depression. |
2006-07-13 |
2023-08-12 |
Not clear |
| Lisa M Bodnar, Keerthy R Sunder, Katherine L Wisne. Treatment with selective serotonin reuptake inhibitors during pregnancy: deceleration of weight gain because of depression or drug? The American journal of psychiatry. vol 163. issue 6. 2006-07-10. PMID:16741197. |
treatment with selective serotonin reuptake inhibitors during pregnancy: deceleration of weight gain because of depression or drug? |
2006-07-10 |
2023-08-12 |
Not clear |
| Mary A Whoole. Depression and cardiovascular disease: healing the broken-hearted. JAMA. vol 295. issue 24. 2006-07-07. PMID:16804154. |
it is not known whether treating depression improves cardiovascular outcomes, but antidepressant treatment with selective serotonin reuptake inhibitors is generally safe, alleviates depression, and improves quality of life. |
2006-07-07 |
2023-08-12 |
Not clear |
| Nicole Praschak-Rieder, Alan A Wilson, Douglas Hussey, Anna Carella, Corie Wei, Nathalie Ginovart, Markus J Schwarz, Johanna Zach, Sylvain Houle, Jeffrey H Meye. Effects of tryptophan depletion on the serotonin transporter in healthy humans. Biological psychiatry. vol 58. issue 10. 2006-07-06. PMID:16026765. |
lowering of brain serotonin by acute tryptophan depletion (td) frequently leads to transient symptoms of depression in vulnerable individuals but not in euthymic healthy subjects with a negative family history of depression. |
2006-07-06 |
2023-08-12 |
human |
| David J Burn, Watcharee Tiangyou, Liesl M Allcock, Jill Davison, Patrick F Chinner. Allelic variation of a functional polymorphism in the serotonin transporter gene and depression in Parkinson's disease. Parkinsonism & related disorders. vol 12. issue 3. 2006-07-06. PMID:16459126. |
allelic variation of a functional polymorphism in the serotonin transporter gene and depression in parkinson's disease. |
2006-07-06 |
2023-08-12 |
Not clear |